查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1784114

全球自我檢測市場

Self-Testing
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球自我檢測市場規模將達到 197 億美元

全球自檢市場規模預計在2024年達到123億美元，預計2024年至2030年期間的複合年成長率為8.1%，到2030年將達到197億美元。套件是本報告分析的細分市場之一，預計其複合年成長率為7.6%，到分析期結束時規模將達到114億美元。設備細分市場在分析期間內的複合年成長率預計為9.3%。

美國市場預計將達到 32 億美元，中國市場複合年成長率將達到 7.9%

美國自我檢測市場規模預計2024年將達到32億美元。作為世界第二大經濟體，中國預計在2030年市場規模將達到32億美元，2024年至2030年的複合年成長率為7.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為7.4%和7.0%。在歐洲，預計德國的複合年成長率約為6.6%。

全球自我檢測市場－主要趨勢與促進因素摘要

自測市場為何如此熱門？

隨著消費者尋求更便利、私密、快速的健康管理診斷方案，自我檢測市場正經歷顯著成長。預防性醫療意識的不斷增強，以及用於檢測感染疾病、不孕症、膽固醇、維生素缺乏症等疾病的家用檢測套組的普及，正在推動市場需求。新冠肺炎疫情加速了自我檢測的普及，快速家用抗原檢測和 PCR 檢測日益普及。診斷技術的進步提高了自我檢測套件的準確性和易用性，使人們無需頻繁就醫即可及早發現健康狀況。此外，遠端醫療服務的興起將自我檢測進一步融入數位醫療生態系統，實現遠距諮詢和治療提案。

哪些技術創新使得自我檢測試劑套件更有效？

診斷領域的最新創新利用微流體、生物感測器和人工智慧 (AI)，顯著提高了自我檢測設備的準確性和易用性。實驗室晶片技術實現了緊湊、經濟高效的檢測解決方案，能夠從少量血液、唾液和尿液樣本中進行精確的生化分析。具有藍牙和智慧型手機連接功能的智慧自檢套件可以即時追蹤檢測結果，使用戶能夠立即與醫療保健提供者共用資料。基於人工智慧的影像識別的整合進一步增強了橫向流動測試的解釋能力，並降低了使用者出錯的風險。此外，基於呼吸的血糖監測儀和基於唾液的基因檢測等非侵入性自檢方法的進步正在擴大家用診斷的覆蓋範圍。

哪些醫療保健垂直領域將推動自我檢測市場的成長？

自測試劑套件正廣泛應用於多個醫療保健領域，包括傳染病篩檢、慢性病管理和個人化醫療。糖尿病領域是自測設備的最大消費者之一，其中連續血糖監測 (CGM) 系統和血糖值試紙對於日常疾病管理至關重要。女性健康領域也不斷發展，生育和妊娠檢測套組也變得越來越先進，普及程度也越來越高。諸如血統和基於 DNA 的健康風險評估等基因自測的興起，進一步擴大了消費者對家用診斷產品的興趣。此外，對預防性醫療保健的日益關注，也推動了對膽固醇、心血管風險評估、腸道微生物組分析等自測解決方案的需求。

哪些因素推動了自我測驗市場的成長？

自我檢測市場的成長受到多種因素的推動，包括健康意識的增強、向預防性醫療保健的轉變以及診斷技術的改進。電子商務和直接面對消費者 (DTC) 醫療保健品牌的擴張使全球消費者更容易獲得自我檢測套件。政府對家用診斷設備的核准和報銷政策的改進進一步推動了市場擴張。遠端醫療和數位健康平台的整合也在推動對自我檢測套件的需求。自我檢測試劑套件可實現遠端患者監控，減輕醫療機構的負擔。隨著自我檢測技術的不斷發展，它提供了更個人化和高效的醫療保健解決方案，進一步擴大了市場。

部分

產品（套件、設備、試紙）；樣本（血液、尿液、糞便等）；應用（血壓測試、糖尿病/血糖值測試、膽固醇/三酸甘油酯測試、懷孕測試、性病測試、尿道感染測試、癌症檢查、乳糜瀉測試、甲狀腺測試、轉氨酶測試、貧血測試、過敏測試等）

受訪公司範例

  • 2San
  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Assure Tech（Hangzhou）Co., Ltd.
  • Becton, Dickinson and Company（BD）
  • bioLytical Laboratories Inc.
  • Bionime Corporation
  • BioReference Laboratories, Inc.
  • Biozek Medical
  • Cardinal Health
  • Celltrion Inc.
  • Eurofins Scientific
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Geratherm Medical AG
  • Gold Standard Diagnostics
  • iHealth Labs Inc.
  • iuvo BioScience
  • Johnson & Johnson Services, Inc.
  • LetsGetChecked
  • Nectar Lifesciences Ltd.
  • OraSure Technologies, Inc.
  • PRIMA Lab SA
  • Quidel Corporation
  • Selfdiagnostics
  • Siemens Healthineers
  • True Diagnostics, Inc.
  • Wondfo

人工智慧整合

全球產業分析師利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 沒有查詢通用的 LLM 或特定產業的SLM，而是建立了一個從世界各地的專家收集的內容庫，其中包括影片錄像、BLOG、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地和進出口（成品和原始設備製造商）情況預測其競爭地位的變化。這種複雜而多面的市場動態預計將以多種方式影響競爭對手，包括銷貨成本(COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP32896

Global Self-Testing Market to Reach US$19.7 Billion by 2030

The global market for Self-Testing estimated at US$12.3 Billion in the year 2024, is expected to reach US$19.7 Billion by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$11.4 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 9.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 7.9% CAGR

The Self-Testing market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 7.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.6% CAGR.

Global Self-Testing Market - Key Trends & Drivers Summarized

Why Is The Self-Testing Market Gaining Popularity?

The self-testing market is witnessing significant growth as consumers seek more convenient, private, and rapid diagnostic solutions for managing their health. The increasing awareness of preventive healthcare, along with the expansion of home-based testing kits for infectious diseases, fertility, cholesterol, and vitamin deficiencies, is driving market demand. The COVID-19 pandemic accelerated the adoption of self-testing, with at-home rapid antigen and PCR tests becoming widely available. With advancements in diagnostic technology, self-testing kits are becoming more accurate and user-friendly, enabling early detection of health conditions without the need for frequent hospital visits. Additionally, the rise of telehealth services is further integrating self-testing into digital healthcare ecosystems, allowing for remote consultation and treatment recommendations.

What Innovations Are Enhancing The Effectiveness Of Self-Testing Kits?

Recent innovations in microfluidics, biosensors, and artificial intelligence (AI)-powered diagnostics are significantly improving the accuracy and usability of self-testing devices. Lab-on-a-chip technology is enabling compact and cost-effective testing solutions, allowing for precise biochemical analysis from a small sample of blood, saliva, or urine. Smart self-testing kits equipped with Bluetooth and smartphone connectivity are allowing real-time tracking of test results, enabling users to share data with healthcare providers instantly. The integration of AI-based image recognition is further enhancing the interpretation of lateral flow tests, reducing the risk of user error. Additionally, advancements in non-invasive self-testing methods, such as breath-based glucose monitors and saliva-based genetic testing, are expanding the scope of home diagnostics.

Which Healthcare Segments Are Driving The Growth Of The Self-Testing Market?

Self-testing kits are becoming widely adopted across multiple healthcare sectors, including infectious disease screening, chronic disease management, and personalized medicine. The diabetes sector remains one of the largest consumers of self-testing devices, with continuous glucose monitoring (CGM) systems and blood sugar test strips being essential for daily disease management. The women’s health segment is also experiencing growth, with fertility and pregnancy test kits becoming more advanced and widely available. The rise of genetic self-testing, including ancestry and DNA health risk assessments, is further expanding consumer interest in at-home diagnostics. Additionally, the growing focus on preventive healthcare is increasing demand for self-testing solutions for cholesterol, cardiovascular risk assessment, and gut microbiome analysis.

What Factors Are Fueling The Growth Of The Self-Testing Market?

The growth of the self-testing market is driven by several factors, including increased health awareness, the shift toward preventive healthcare, and improvements in diagnostic technology. The expansion of e-commerce and direct-to-consumer (DTC) healthcare brands is making self-testing kits more accessible to consumers worldwide. Government approvals for at-home diagnostic devices, along with improved reimbursement policies, are further supporting market expansion. The integration of telemedicine and digital health platforms is also driving demand for self-testing kits, as they enable remote patient monitoring and reduce the burden on healthcare facilities. As self-testing technology continues to evolve, the market is expected to expand, offering more personalized and efficient healthcare solutions.

SCOPE OF STUDY:

The report analyzes the Self-Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Kits, Devices, Strips); Sample (Blood, Urine, Stool, Others); Application (Blood Pressure Test, Diabetes & Glucose Tests, Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • 2San
  • Abbott Laboratories
  • Access Bio, Inc.
  • ACON Laboratories, Inc.
  • ARKRAY, Inc.
  • Assure Tech (Hangzhou) Co., Ltd.
  • Becton, Dickinson and Company (BD)
  • bioLytical Laboratories Inc.
  • Bionime Corporation
  • BioReference Laboratories, Inc.
  • Biozek Medical
  • Cardinal Health
  • Celltrion Inc.
  • Eurofins Scientific
  • Everlywell, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Geratherm Medical AG
  • Gold Standard Diagnostics
  • iHealth Labs Inc.
  • iuvo BioScience
  • Johnson & Johnson Services, Inc.
  • LetsGetChecked
  • Nectar Lifesciences Ltd.
  • OraSure Technologies, Inc.
  • PRIMA Lab SA
  • Quidel Corporation
  • Selfdiagnostics
  • Siemens Healthineers
  • True Diagnostics, Inc.
  • Wondfo

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Self-Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Convenient and At-Home Health Solutions Drives Growth in Self-Testing Products
    • The Rise of Chronic Disease Management and Preventative Healthcare Expands Market Opportunity for Self-Testing Solutions
    • Surge in Consumer Awareness of Health and Wellness Drives Adoption of Self-Testing Kits for Home Use
    • Technological Advancements in Diagnostics and Testing Devices Propel Market Growth for Self-Testing Products
    • Growing Preference for Privacy and Confidentiality in Health Management Strengthens the Demand for Self-Testing Solutions
    • The Expansion of Remote Healthcare and Telemedicine Services Creates New Opportunities for Self-Testing Products
    • Increasing Regulatory Approvals and Standards for Self-Testing Devices Accelerates Consumer Confidence and Market Growth
    • The Growth of the Wellness and Fitness Sector Strengthens the Adoption of Self-Testing for Health Metrics
    • Rising Healthcare Costs Drive Demand for Affordable, At-Home Testing Solutions for Chronic Conditions
    • Increasing Investment in Digital Health and Mobile Health Apps Expands the Role of Self-Testing in Remote Monitoring
    • Consumer Demand for Real-Time, Actionable Health Data Drives the Growth of Self-Testing Kits in Multiple Market Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Self-Testing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Strips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Strips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cholesterol & Triglycerides Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Cholesterol & Triglycerides Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Pregnancy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Pregnancy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for STD Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for STD Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Urinary Tract Infection Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Urinary Tract Infection Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cancer Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cancer Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Celiac disease Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Celiac disease Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Thyroid Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Thyroid Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Transaminase Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Transaminase Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Anemia Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Anemia Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Allergy Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Allergy Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Pressure Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Blood Pressure Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Diabetes & Glucose Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 35: World 6-Year Perspective for Diabetes & Glucose Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 36: World Recent Past, Current & Future Analysis for Blood by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 37: World 6-Year Perspective for Blood by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Urine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World 6-Year Perspective for Urine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Stool by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: World 6-Year Perspective for Stool by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 42: World Recent Past, Current & Future Analysis for Other Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 43: World 6-Year Perspective for Other Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 46: USA Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: USA 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 48: USA Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: USA 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 54: Canada Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Canada 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • JAPAN
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • CHINA
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 64: China Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • EUROPE
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Self-Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Self-Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • FRANCE
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 76: France Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • GERMANY
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • UNITED KINGDOM
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 94: UK Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: UK 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Self-Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 106: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Asia-Pacific 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 112: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Product - Kits, Devices and Strips - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of World 6-Year Perspective for Self-Testing by Product - Percentage Breakdown of Value Sales for Kits, Devices and Strips for the Years 2025 & 2030
    • TABLE 114: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Application - Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Rest of World 6-Year Perspective for Self-Testing by Application - Percentage Breakdown of Value Sales for Cholesterol & Triglycerides Tests, Pregnancy Test, STD Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Other Applications, Blood Pressure Test and Diabetes & Glucose Tests for the Years 2025 & 2030
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Self-Testing by Sample - Blood, Urine, Stool and Other Samples - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Rest of World 6-Year Perspective for Self-Testing by Sample - Percentage Breakdown of Value Sales for Blood, Urine, Stool and Other Samples for the Years 2025 & 2030

IV. COMPETITION